Skip to main content
SpringerLink
Log in

Early Clinical Experience of Hormonal Therapy in the Brain-Dead Potential Organ Donor

  • Chapter
  • First Online:
The Brain-Dead Organ Donor

  • 1561 Accesses

Abstract

Two types of changes have been documented in the brain-dead potential organ donor. The first is due to diffuse vascular and interstitial injury and the second results from diffuse metabolic cellular disturbances. The former is secondary to the autonomic “storm” that takes place from excessive sympathetic activity during the development of brain death. The latter is due to endocrine abnormalities following loss of hypothalamic control, leading to a state of progressive inhibition of aerobic metabolism. Several clinical studies failed to document low levels of free T3, T4, cortisol, and/or insulin after brain death and/or failed to demonstrate any significant beneficial cardiac and circulatory effect of T3/T4 administration. However, the effects of hormonal therapy were tested by other groups in the management of the brain-dead potential organ donor and demonstrated a beneficial clinical effect in the hemodynamically unstable donor. Data compiled by the United Network of Organ Sharing (UNOS) from a large number of transplant centers have provided supportive evidence for the beneficial effects of hormonal therapy on donor organ function both before and after the transplant procedure. In 2009, almost 50% of brain-dead potential donors in the USA received some form of hormonal replacement therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Novitzky D, Cooper DKC, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation. 1987;43: 852–4.

    PubMed  CAS  Google Scholar 

  2. Novitzky D, Cooper DKC, Human PA, Reichart B, Zuhdi N. Triiodothyronine therapy for heart donor and recipient. J Heart Transplant. 1988;7:370–6.

    PubMed  CAS  Google Scholar 

  3. Novitzky D, Cooper DKC, Chaffin JS, Greer AE, DeBault LE, Zuhdi N. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation. 1990;49:311–6.

    Article  PubMed  CAS  Google Scholar 

  4. Cooper DKC, Novitzky D, Wicomb WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl. 1989;71:261–6.

    PubMed  CAS  Google Scholar 

  5. Schrader H, Krogness K, Aakvaag A, Sortland O, Purvis K. Changes of pituitary hormones in brain death. Acta Neurochir. 1980;52:239–48.

    Article  CAS  Google Scholar 

  6. Hall GM, Mashiter K, Lumley J, Robson JG. Hypothalamic-pituitary function in the “brain-dead” patient. Lancet. 1980;2:1259.

    Article  PubMed  CAS  Google Scholar 

  7. Yoshioka T, Sugimoto H, Uenishi M, et al. Prolonged hemodynamic maintenance by the combined administration of vasopressin and epinephrine in brain death: a clinical study. Neurosurgery. 1986;18:565–7.

    Article  PubMed  CAS  Google Scholar 

  8. Kinoshita Y, Okamoto K, Yahata K, et al. Clinical and pathological changes of the heart in brain death maintained with vasopressin and epinephrine. Pathol Res Pract. 1990;186:173–9.

    Article  PubMed  CAS  Google Scholar 

  9. Kinoshita Y, Yahata K, Yoshioka T, Onishi S, Sugimoto T. Long-term renal preservation after brain death maintained with vasopressin and epinephrine. Transpl Int. 1990;3:15–8.

    Article  PubMed  CAS  Google Scholar 

  10. Sugimoto T, Sakano T, Kinoshita Y, Masui M, Yoshioka T. Morphological and functional alterations of the hypothalamic-pituitary system in brain death with long-term bodily living. Acta Neurochir (Wien). 1992;115:31–6.

    Article  CAS  Google Scholar 

  11. Rowiński W, Lao M, Cajzner S, et al. The influence of endocrine changes in donors and recipients on the immediate outcome of kidney transplantation. Transplant Proc. 1996;28:3494–6.

    PubMed  Google Scholar 

  12. Chen JM, Cullinane S, Spanier TB, et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation. 1999;100(19 Suppl):II244–6.

    Google Scholar 

  13. Gifford RR, Weaver AS, Burg JE, Romano PJ, Demers LM, Pennock JL. Thyroid hormone levels in heart and kidney cadaver donors. J Heart Transplant. 1986;5: 249–53.

    PubMed  CAS  Google Scholar 

  14. Howlett TA, Keogh AM, Perry L, Touzel R, Rees LH. Anterior and posterior pituitary function in brain-stem-dead donors. A possible role for hormonal replacement therapy. Transplantation. 1989;47: 828–34.

    Article  PubMed  CAS  Google Scholar 

  15. Arita K, Uozumi T, Oki S, Ohtani M, Mikami T. The function of the hypothalamo—pituitary axis in the brain-dead patients. Acta Neurochir. 1993;123: 64–75.

    Article  CAS  Google Scholar 

  16. Szostek M, Gaciong Z, Cajzner S, et al. The effect of endocrine disturbances on hemodynamic stability of brain-dead organ donors. I. Thyroid function. Ann Transplant. 1996;1:27–30.

    PubMed  CAS  Google Scholar 

  17. Szostek M, Gaciong Z, Danielelewicz R, et al. Influence of thyroid function in brain stem death donors on kidney allograft function. Transplant Proc. 1997;29:3354–6.

    Article  PubMed  CAS  Google Scholar 

  18. Bohatyrewicz R, Banas I, Zembala M, et al. Serum melatonin levels in brain-dead organ donors. Transplant Proc. 1996;28:163–4.

    PubMed  CAS  Google Scholar 

  19. Powner DJ, Hendrich A, Lagler RG, Ng RH, Madden RL. Hormonal changes in brain-dead patients. Crit Care Med. 1990;18:702–8.

    Article  PubMed  CAS  Google Scholar 

  20. Gramm HJ, Meinhold H, Bickel U, et al. Acute endocrine failure after brain death? Transplantation. 1992;54:851–7.

    Article  PubMed  CAS  Google Scholar 

  21. Randell TT, Höckerstedt KA. Triiodothyronine treatment in brain-dead multiorgan donors—a controlled study. Transplantation. 1992;54:736–8.

    Article  PubMed  CAS  Google Scholar 

  22. Randell TT, Höckerstedt KA. Triiodothyronine treatment is not indicated in brain-dead multiorgan donors: a controlled study. Transplant Proc. 1993;25:1552–3.

    PubMed  CAS  Google Scholar 

  23. Powner DJ, Hernandez M. A review of thyroid hormone administration during adult donor care. Prog Transplant. 2005;15:202–7.

    PubMed  Google Scholar 

  24. Venkateswaran RV, Dronavalli V, Lambert PA, et al. The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal theray. Transplantation. 2009;88:582–8.

    Article  PubMed  CAS  Google Scholar 

  25. Venkateswaran RV, Steeds RP, Quinn DW, et al. The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur Heart J. 2009;30:1690–1.

    Article  Google Scholar 

  26. Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor management increases the retrieval of lungs for transplantation. Ann Thorac Surg. 2008;85: 278–86.

    Article  PubMed  Google Scholar 

  27. García-Fages LC, Antolín M, Cabrer C, et al. Effects of substitutive triiodothyronine therapy on intracellular nucleotide levels in donor organs. Transplant Proc. 1991;23:2495–6.

    PubMed  Google Scholar 

  28. Taniguchi S, Kitamura S, Kawachi K, Doi Y, Aoyama N. Effects of hormonal supplements on the maintenance of cardiac function in potential donor patients after cerebral death. Eur J Cardiothorac Surg. 1992;6:96–101.

    Article  PubMed  CAS  Google Scholar 

  29. Pennefather SH, Bullock RE. Triiodothyronine treatment in brain-dead multiorgan donors—a controlled study. Transplantation. 1993;55:144.

    Article  Google Scholar 

  30. Orlowski JP. Use of T4 for managing hemodynamically recovery systems. Transplant Manage. 1990;2:13.

    Google Scholar 

  31. Orlowski JP. Evidence that thyroxine (T4) is effective as a hemodynamic rescue agent in management of organ donors. Transplantation. 1993;55:959–60.

    Article  PubMed  CAS  Google Scholar 

  32. Orlowski JP, Spees EK. Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months. Transplant Proc. 1993;25:1535.

    PubMed  CAS  Google Scholar 

  33. Jeevanandam V, Todd B, Hellman S, Eldridge C, McClurken J, Addonizio VP. Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: creating a larger donor pool. Transplant Proc. 1993;25:3305–6.

    PubMed  CAS  Google Scholar 

  34. Jeevanandam V, Todd B, Regillo T, Hellman S, Eldridge C, McClurken J. Reversal of donor myo­cardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant. 1994;13: 681–7.

    PubMed  CAS  Google Scholar 

  35. Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid. 1997;7:139–45.

    Article  PubMed  CAS  Google Scholar 

  36. Snow TR, Deal MT, Connelly TS, Yokoyama Y, Novitzky D. Acute inotropic response of rabbit papillary muscle to triiodothyronine. Cardiology. 1992;80:111–2.

    Article  Google Scholar 

  37. Ririe DG, Butterworth IV JF, Royster RL, MacGregor DA, Zaloga GP. Triiodothyronine increases contractility independent of β-adrenergic receptors or stimulation of cyclic-3′,5′-adenosine monophosphate. Anesthesiology. 1995;82:1004–12.

    Article  PubMed  CAS  Google Scholar 

  38. Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005;26:704–28.

    Article  PubMed  CAS  Google Scholar 

  39. Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the “unacceptable” donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant. 1995;14:734–42.

    PubMed  CAS  Google Scholar 

  40. Darracott-Canković S, Hutter J, Wallwork J, Wheeldon D, English TA. Biopsy assessment of myocardial preservation in 160 human donor hearts. Transplant Proc. 1988;20(5 Suppl 7):44–8.

    PubMed  Google Scholar 

  41. Darracott-Cankovic S, Stovin PG, Wheeldon D, Wallwork J, Wells F, English TA. Effect of donor heart damage on survival after transplantation. Eur J Cardiothorac Surg. 1989;3:525–32.

    Article  PubMed  CAS  Google Scholar 

  42. Salim A, Vassiliu P, Velmahos GC, et al. The role of thyroid hormone administration in potential organ donors. Arch Surg. 2001;136:1377–80.

    Article  PubMed  CAS  Google Scholar 

  43. Salim A, Velmahos GC, Brown C, Belzberg H, Demetriades D. Aggressive organ donor management significantly increases the number of organs available for transplantation. J Trauma. 2005;58:991–4.

    Article  PubMed  Google Scholar 

  44. Salim A, Martin M, Brown C, et al. Using thyroid hormone in brain-dead donors to maximize the number of organs available for transplantation. Clin Transplant. 2007;21:405–9.

    Article  PubMed  Google Scholar 

  45. Zuppa AF, Nadkarni V, Davis L, et al. The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med. 2004;32:2318–22.

    PubMed  CAS  Google Scholar 

  46. Macoviak JA, McDougall IR, Bayer MF, Brown M, Tazelaar H, Stinson EB. Significance of thyroid dysfunction in human cardiac allograft procurement. Transplantation. 1987;43:824–6.

    PubMed  CAS  Google Scholar 

  47. Keogh AM, Howlett TA, Parry L, Rees LH. Pituitary function in brain-stem dead organ donors: a prospective study. Transplant Proc. 1988;20:728–30.

    Google Scholar 

  48. Robertson KM, Hramiak IM, Gelb AW. Endocrine changes and haemodynamic stability after brain death. Transplant Proc. 1989;21:1197–8.

    PubMed  CAS  Google Scholar 

  49. Koller J, Wieser C, Gottardis M, Kornberger R, Furtwängler W, Königsrainer A, Margreiter R. Thyroid hormones and their impact on the hemodynamic and metabolic stability of organ donors and on kidney graft function after transplantation. Transplant Proc. 1990;22:355–7.

    PubMed  CAS  Google Scholar 

  50. Masson F, Thicoïpe M, Latapie MJ, Maurette P. Thyroid function in brain-dead donors. Transpl Int. 1990;3:226–33.

    PubMed  CAS  Google Scholar 

  51. Mariot J, Jacob F, Voltz C, Perrier JF, Strub P. Evaluation of tri-iodothyronine and cortisol treatment in the brain-dead patient. Ann Fr Anesth Reanim. 1991;10:321–8.

    Article  PubMed  CAS  Google Scholar 

  52. Harms J, Isemer FE, Kolenda H. Hormonal alteration and pituitary function during course of brain-stem death in potential organ donors. Transplant Proc. 1991;23:2614–6.

    PubMed  CAS  Google Scholar 

  53. Mariot J, Sadoune LO, Jacob F, Dousset B, Perrier JF, Jacob C, Strub P, Voltz C. Hormone levels, hemodynamics, and metabolism in brain-dead organ donors. Transplant Proc. 1995;27:793–4.

    PubMed  CAS  Google Scholar 

  54. Washida M, Okamoto R, Manaka D, et al. Beneficial effect of combined 3,5,3′-triiodothyronine and vasopressin administration of hepatic energy status and systemic hemodynamics after brain death. Transplantation. 1992;54:44–9.

    Article  PubMed  CAS  Google Scholar 

  55. Colpart JJ, Ramella S, Bret M, et al. Hypophysis-thyroid axis disturbances in human brain-dead donors. Transplant Proc. 1996;28:171–2.

    PubMed  CAS  Google Scholar 

  56. Goarin JP, Cohen S, Riou B, Jacquens Y, Guesde R, Le Bret F, Aurengo A, Coriat P. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg. 1996;83:41–7.

    PubMed  CAS  Google Scholar 

  57. Timek T, Bonz A, Dillmann R, Vahl CF, Hagl S. The effect of triiodothyronine on myocardial contractile performance after epinephrine exposure: implications for donor heart management. J Heart Lung Transplant. 1998;17:931–40.

    PubMed  CAS  Google Scholar 

  58. Pérez-Blanco A, Caturla-Such J, Cánovas-Robles J, Sanchez-Payá J. Efficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration. Intensive Care Med. 2005;31:943–8.

    Article  PubMed  Google Scholar 

  59. Nicolas-Robin A, Amour J, Ibanez-Esteve C, Coriat P, Riou B, Langeron O. Effect of glucose-insulin-­potassium in severe acute heart failure after brain death. Crit Care Med. 2008;36:2740–5.

    Article  PubMed  CAS  Google Scholar 

  60. Abdelnour T, Ricke S. Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant. J Heart Lung Transplant. 2009;28:480–5.

    Article  PubMed  Google Scholar 

  61. Nath DS, Basha HI, Liu MH, Moazami N, Ewald GA. Increased recovery of thoracic organs after hormonal resuscitation therapy. J Heart Lung Transplant. 2010;29:594–6.

    Article  PubMed  Google Scholar 

  62. Masson F, Thicoipe M, Gin H, et al. The endocrine pancreas in brain-dead donors. A prospective study in 25 patients. Transplantation. 1993;56:363–7.

    Article  PubMed  CAS  Google Scholar 

  63. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 1998;17:423–9.

    PubMed  CAS  Google Scholar 

  64. Gatti S, Colombo G, Turcatti F, et al. Reduced expression of the melanocortin-1 receptor in human liver during brain death. Neuroimmunomodulation. 2006;13:51–5.

    Article  PubMed  CAS  Google Scholar 

  65. Rosendale JD, Chabalewski FL, McBride MA, et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant. 2002;2:761–8.

    Article  PubMed  Google Scholar 

  66. Rosengard BR, Feng S, Alfrey EJ, et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant. 2002;2:701–11.

    Article  PubMed  Google Scholar 

  67. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28–29, 2001, Crystal City, Va. Circulation. 2002;106:836–41.

    Article  PubMed  Google Scholar 

  68. Zaroff JG, Rosengard BR, Armstrong WF, et al. Maximizing use of organs recovered from the cadaver donor: cardiac recommendations. J Heart Lung Transplant. 2002;21:1153–60.

    Article  Google Scholar 

  69. Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation. 2003;75:482–7.

    Article  PubMed  Google Scholar 

  70. Rosendale JD, Kauffman HM, McBride MA, et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation. 2003;75:1336–41.

    Article  PubMed  Google Scholar 

  71. Novitzky D, Cooper DKC, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation. 2006;82:1396–401.

    Article  PubMed  CAS  Google Scholar 

  72. Canadian Council for Donation and Transplantation Forum. Medical management to optimize donor organ potential. 2004. http://www.ccdt.ca/external/english/publications/organ-donor-guidelines.pdf. Accessed 15 Feb 06.

  73. Cooper DKC, Novitzky D, Wicomb WN, Basker M, Rosendale JD, Kauffman HM. A review of studies relating to thyroid hormone therapy in brain-dead organ donors and patients undergoing cardiopulmonary bypass. Front Biosci. 2009;14:3750–70.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors are indebted to Zhibao Mi, MA, PhD, of the VA Cooperative Studies Program Coordinating Center of the VA Maryland Healthcare Systems for valuable biostatistical analyses.

Author information

Authors and Affiliations

  1. Department of Surgery, Tampa VA Medical Center, Tampa, FL, USA

    Dimitri Novitzky M.D., Ph.D., F.C.S. (SA)

  2. Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Burcin Ekser M.D. & David K. C. Cooper M.A., Ph.D., M.D., M.S., D.Sc.(Med), F.R.C.S., F.A.C.S.

Authors
  1. Dimitri Novitzky M.D., Ph.D., F.C.S. (SA)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Burcin Ekser M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David K. C. Cooper M.A., Ph.D., M.D., M.S., D.Sc.(Med), F.R.C.S., F.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David K. C. Cooper M.A., Ph.D., M.D., M.S., D.Sc.(Med), F.R.C.S., F.A.C.S. .

Editor information

Editors and Affiliations

  1. Tampa VA Medical Center, Surgery, University of South Florida, Bruce B. Downs Blvd 12901, Tampa, 33612, Florida, USA

    Dimitri Novitzky

  2. Thomas E. Starzl Transplantation Institu, Department of Surgery, University of Pittsburgh Medical Center, Lothrop Street 200, Pittsburgh, 15213, Pennsylvania, USA

    David K C Cooper

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Novitzky, D., Ekser, B., Cooper, D.K.C. (2013). Early Clinical Experience of Hormonal Therapy in the Brain-Dead Potential Organ Donor. In: Novitzky, D., Cooper, D. (eds) The Brain-Dead Organ Donor. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4304-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4304-9_16

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4303-2

  • Online ISBN: 978-1-4614-4304-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation